Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
Add more filters










Database
Publication year range
1.
Am J Transplant ; 17(6): 1490-1501, 2017 Jun.
Article in English | MEDLINE | ID: mdl-27888555

ABSTRACT

Renal operationally tolerant patients (TOL) display a defect in B cell differentiation, with a deficiency in plasma cells. Recently described, T follicular helper (Tfh) cells play a critical role in B cell differentiation. We analyzed blood Tfh subsets in TOL and transplanted patients with stable graft function under immunosuppression (STA). We observed a reduced proportion of blood activated and highly functional Tfh subsets in TOL, without affecting Tfh absolute numbers. Functionally, Tfh cells from TOL displayed a modified gene expression profile, failed to produce interleukin-21, and were unable to induce IgG production by naive B cells. This Tfh defect is linked to a low incidence of postgraft de novo donor-specific antibody (dnDSA) immunization, suggesting that the lack of Tfh cells in TOL may induce a protolerogenic environment with reduced risk of developing dnDSA. Finally, we showed that elevated Tfh in STA precedes the occurrence of dnDSA during an alloresponse. These data provide new insights into the mechanisms of antibody response in operational tolerance. Disrupted homeostasis and impaired Tfh function in TOL could lead to a reduced risk of developing dnDSA and suggest a predictive role of blood Tfh cells on the occurrence of dnDSA in transplant recipients.


Subject(s)
B-Lymphocytes/immunology , Graft Rejection/immunology , Immune Tolerance/immunology , Isoantibodies/immunology , Kidney Transplantation , Plasma Cells/immunology , T-Lymphocytes, Helper-Inducer/immunology , Adult , Aged , Antibody Formation/immunology , Cell Differentiation , Female , Follow-Up Studies , Glomerular Filtration Rate , Graft Survival , Humans , Interleukins/metabolism , Kidney Failure, Chronic/surgery , Kidney Function Tests , Lymphocyte Activation , Male , Middle Aged , Prognosis , Risk Factors , T-Lymphocytes, Helper-Inducer/pathology , Transplant Recipients
2.
Allergy ; 69(11): 1454-63, 2014 Nov.
Article in English | MEDLINE | ID: mdl-25060230

ABSTRACT

B cells are essentially described for their capacity to produce antibodies ensuring anti-infectious immunity or deleterious responses in the case of autoimmunity or allergy. However, abundant data described their ability to restrain inflammation by diverse mechanisms. In allergy, some regulatory B-cell subsets producing IL-10 have been recently described as potent suppressive cells able to restrain inflammatory responses both in vitro and in vivo by regulatory T-cell differentiation or directly inhibiting T-cell-mediated inflammation. A specific deficit in regulatory B cells participates to more severe allergic inflammation. Induction of allergen tolerance through specific immunotherapy induces a specific expansion of these cells supporting their role in establishment of allergen tolerance. However, the regulatory functions carried out by B cells are not exclusively IL-10 dependent. Indeed, other regulatory mechanisms mediated by B cells are (i) the production of TGF-ß, (ii) the promotion of T-cell apoptosis by Fas-Fas ligand or granzyme-B pathways, and (iii) their capacity to produce inhibitory IgG4 and sialylated IgG able to mediate anti-inflammatory mechanisms. This points to Bregs as interesting targets for the development of new therapies to induce allergen tolerance. In this review, we highlight advances in the study of regulatory mechanisms mediated by B cells and outline what is known about their phenotype as well as their suppressive role in allergy from studies in both mice and humans.


Subject(s)
B-Lymphocytes, Regulatory/immunology , Hypersensitivity/immunology , Animals , B-Lymphocytes, Regulatory/metabolism , Humans , Hypersensitivity/metabolism , Immunomodulation , Inflammation/immunology , Inflammation/metabolism , Interleukin-10/biosynthesis
3.
Am J Transplant ; 13(10): 2567-76, 2013 10.
Article in English | MEDLINE | ID: mdl-23919486

ABSTRACT

The angiotensin II type 1 receptor (AT1R) is an emerging target of functional non-HLA antibodies (Ab). We examined the potential of determining the degree of presensitization against AT1R as a risk factor for graft survival and acute rejection (AR). The study included 599 kidney recipients between 1998 and 2007. Serum samples were analyzed in a blinded fashion for anti-AT1R antibodies (AT1R-Abs) using a quantitative solid-phase assay. A threshold of AT1R-Ab levels was statistically determined at 10 U based on the time to graft failure. An extended Cox model determined risk factors for occurrence of graft failure and a first AR episode. AT1R-Abs >10 U were detected in 283 patients (47.2%) before transplantation. Patients who had a level of AT1R-Abs >10 U had a 2.6-fold higher risk of graft failure from 3 years posttransplantation onwards (p = 0.0005) and a 1.9-fold higher risk of experiencing an AR episode within the first 4 months of transplantation (p = 0.0393). Antibody-mediated rejection (AMR) accounted for 1/3 of AR, whereby 71.4% of them were associated with >10 U of pretransplant AT1R-Abs. Pretransplant anti-AT1R-Abs are an independent risk factor for long-term graft loss in association with a higher risk of early AR episodes.


Subject(s)
Autoantibodies/blood , Graft Rejection/immunology , Graft Survival/immunology , Kidney Transplantation , Receptor, Angiotensin, Type 1/immunology , Transplantation Immunology , Acute Disease , Adult , Autoantibodies/immunology , Enzyme-Linked Immunosorbent Assay , Female , Follow-Up Studies , Graft Rejection/blood , Graft Rejection/diagnosis , HLA Antigens/immunology , Humans , Kidney Diseases/blood , Kidney Diseases/surgery , Male , Middle Aged , Preoperative Care , Prospective Studies , Transplantation, Homologous
4.
Am J Transplant ; 12(10): 2754-62, 2012 Oct.
Article in English | MEDLINE | ID: mdl-22883025

ABSTRACT

There are lines of evidence that B cells may play a role in transplantation. B cell activating factor, BAFF, is a homotrimer that has been shown to play a role in B cell survival, maturation and activation. To date, little is known of the role of BAFF and its receptors in transplantation. We analyzed the level of BAFF mRNA and its soluble protein, as well as transcripts coding for its receptors, BAFF-R, TACI and BCMA, in the blood of 143 patients with stable kidney transplant function 5 years or more posttransplantation. Three endpoints were analyzed: the time to renal dysfunction, the time to appearance of anti-HLA antibodies and the time to development of donor-specific antibodies. We established threshold values for BAFF and BAFF-R and showed that (1) stable patients with high BAFF-R levels had a higher risk of developing graft dysfunction, (2) patients with lower levels of BAFF transcripts or a higher level of soluble BAFF had a significantly higher risk of developing donor-specific antibodies. These data suggest that BAFF constitutes a risk factor for renal graft dysfunction and development of donor-specific antibodies. They also suggest that agents targeting BAFF-R interactions may offer new therapeutic opportunities in transplantation.


Subject(s)
Antibody Formation , B-Cell Activating Factor/metabolism , B-Cell Activation Factor Receptor/metabolism , Kidney Transplantation , Tissue Donors , Female , Humans , Male , Risk Factors
5.
J Invertebr Pathol ; 106(2): 179-91, 2011 Feb.
Article in English | MEDLINE | ID: mdl-20833182

ABSTRACT

Several Vibrio species are known to be pathogenic to the Pacific oyster Crassostrea gigas. Survival varies according to pathogen exposure and high mortality events usually occur in summer during gametogenesis. In order to study the effects of gametogenetic status and ploidy (a factor known to affect reproduction allocation in oysters) on vibriosis survival, we conducted two successive experiments. Our results demonstrate that a common bath challenge with pathogenic Vibrio splendidus and Vibrio aestuarianus on a mixture of mature, spawning and non-mature oysters can lead to significant mortality. Previous bath challenges, which were done using only non-mature oysters, had not produced mortality. Immunohistochemical analyses showed the affinity of Vibrio for gonadic tissues, highlighting the importance of sexual maturity for vibriosis infection processes in oysters. Mortality rate results showed poor repeatability between tanks, however, in this bath challenge. We then tested a standardized and repeatable injection protocol using two different doses of the same combination of two Vibrio species on related diploid and triploid oysters at four different times over a year. Statistical analyses of mortality kinetics over a 6-day period after injection revealed that active gametogenesis periods correspond to higher susceptibility to vibriosis and that there is a significant interaction of this seasonal effect with ploidy. However, no significant advantage of triploidy was observed. Triploid oysters even showed lower survival than diploid counterparts in winter. Results are discussed in relation to differing energy allocation patterns between diploid and triploid Pacific oysters.


Subject(s)
Crassostrea/microbiology , Crassostrea/physiology , Vibrio/isolation & purification , Animals , Disease Susceptibility/physiopathology , Gametogenesis/physiology , Reproduction/physiology , Vibrio Infections/physiopathology
6.
Rev Med Interne ; 31(12): e1-3, 2010 Dec.
Article in French | MEDLINE | ID: mdl-20627481

ABSTRACT

We report a 62-year-old patient who presented with a several month history of a peripheral sensory neuropathy with ataxia that was attributed to a chronic immune demyelinating polyneuropathy but was resistant to corticosteroid therapy. Diagnostic workup finally showed a high serum level of pyridoxin related to a chronic intake of oral vitamin medication for several years. We discuss the link between the clinical and electrophysiological manifestations of the chronic polyneuropathy, based on similar reported observations in the literature. This observation highlights the possibility of important long-term deleterious effects of vitamin oral supplementations, particularly pyridoxin.


Subject(s)
Ataxia/chemically induced , Polyradiculoneuropathy, Chronic Inflammatory Demyelinating/chemically induced , Vitamin B 6/adverse effects , Vitamin B Complex/adverse effects , Chronic Disease , Glucocorticoids/therapeutic use , Humans , Male , Middle Aged , Polyradiculoneuropathy, Chronic Inflammatory Demyelinating/diagnosis , Polyradiculoneuropathy, Chronic Inflammatory Demyelinating/drug therapy , Treatment Outcome , Vitamin B 6/administration & dosage , Vitamin B 6/blood , Vitamin B Complex/administration & dosage , Vitamin B Complex/blood
7.
Appl Environ Microbiol ; 73(22): 7456-64, 2007 Nov.
Article in English | MEDLINE | ID: mdl-17720845

ABSTRACT

Fluorescence in situ hybridization (FISH) was used for direct detection of Escherichia coli on pipe surfaces and coupons in drinking water distribution networks. Old cast iron main pipes were removed from water distribution networks in France, England, Portugal, and Latvia, and E. coli was analyzed in the biofilm. In addition, 44 flat coupons made of cast iron, polyvinyl chloride, or stainless steel were placed into and continuously exposed to water on 15 locations of 6 distribution networks in France and Latvia and examined after 1 to 6 months exposure to the drinking water. In order to increase the signal intensity, a peptide nucleic acid (PNA) 15-mer probe was used in the FISH screening for the presence or absence of E. coli on the surface of pipes and coupons, thus reducing occasional problems of autofluorescence and low fluorescence of the labeled bacteria. For comparison, cells were removed from the surfaces and examined with culture-based or enzymatic (detection of beta-d-glucuronidase) methods. An additional verification was made by using PCR. Culture method indicated presence of E. coli in one of five pipes, whereas all pipes were positive with the FISH methods. E. coli was detected in 56% of the coupons using PNA FISH, but no E. coli was detected using culture or enzymatic methods. PCR analyses confirmed the presence of E. coli in samples that were negative according to culture-based and enzymatic methods. The viability of E. coli cells in the samples was demonstrated by the cell elongation after resuscitation in low-nutrient medium supplemented with pipemidic acid, suggesting that the cells were present in an active but nonculturable state, unable to grow on agar media. E. coli contributed to ca. 0.001 to 0.1% of the total bacterial number in the samples. The presence and number of E. coli did not correlate with any of physical and/or chemical characteristic of the drinking water (e.g., temperature, chlorine, or biodegradable organic matter concentration). We show here that E. coli is present in the biofilms of drinking water networks in Europe. Some of the cells are metabolically active but are often not detected due to limitations of traditionally used culture-based methods, indicating that biofilm should be considered as a reservoir that must be investigated further in order to evaluate the risk for human health.


Subject(s)
Biofilms , Escherichia coli/genetics , Water Microbiology , Water Supply/analysis , DNA, Bacterial/genetics , England , Environmental Monitoring/methods , Escherichia coli/isolation & purification , France , In Situ Hybridization, Fluorescence , Latvia , Polymerase Chain Reaction , Portugal , RNA, Ribosomal, 16S/genetics , Water Purification/instrumentation
SELECTION OF CITATIONS
SEARCH DETAIL
...